Citigroup
CMPI

Citigroup’s Checkmate Pharmaceuticals, Inc. Common Stock CMPI Stock Holding History

Citigroup’s Portfolio CMPI Stock Details CMPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1
Closed – – 6496
2021
Q2 		$0 Sell
1
-621
-100% -$4.39K ﹤0.01% 6549
2021
Q1 		$8K Sell
622
-397
-39% -$5.64K ﹤0.01% 5785
2020
Q4 		$15K Buy
1,019
+777
+321% +$9.9K ﹤0.01% 6812
2020
Q3 		$3K Buy
+242
New +$3.1K ﹤0.01% 7262

Other funds holding CMPI

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Citigroup's CMPI Position: Q3 2021 in Review

Citigroup sold out of Checkmate Pharmaceuticals, Inc. Common Stock (CMPI) in Q3 2021, closing a stake of 1 share.

Citigroup first reported a position in CMPI in Q3 2020 and held it in 4 quarters. The position peaked at $15K in Q4 2020. 31 funds tracked by Wall St. Rank hold CMPI as of Q3 2021.

  • Citigroup reported no remaining Checkmate Pharmaceuticals, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Citigroup sold 1 Checkmate Pharmaceuticals, Inc. Common Stock share in Q3 2021.
  • Citigroup first reported a position in Checkmate Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • Citigroup's Checkmate Pharmaceuticals, Inc. Common Stock position peaked at $15K in Q4 2020.
  • 31 funds tracked by Wall St. Rank held Checkmate Pharmaceuticals, Inc. Common Stock as of Q3 2021.

Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.